Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Operating Income: 2012-2024

Historic Operating Income for Ascendis Pharma A (ASND) over the last 13 years, with Dec 2024 value amounting to -$301.7 million.

  • Ascendis Pharma A's Operating Income rose 112.10% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$156.3 million, marking a year-over-year increase of 54.37%. This contributed to the annual value of -$301.7 million for FY2024, which is 38.44% up from last year.
  • Latest data reveals that Ascendis Pharma A reported Operating Income of -$301.7 million as of FY2024, which was up 38.44% from -$490.1 million recorded in FY2023.
  • In the past 5 years, Ascendis Pharma A's Operating Income registered a high of -$301.7 million during FY2024, and its lowest value of -$573.2 million during FY2022.
  • In the last 3 years, Ascendis Pharma A's Operating Income had a median value of -$490.1 million in 2023 and averaged -$455.0 million.
  • As far as peak fluctuations go, Ascendis Pharma A's Operating Income slumped by 166,402.71% in 2020, and later spiked by 38.44% in 2024.
  • Ascendis Pharma A's Operating Income (Yearly) stood at -$377.5 million in 2020, then plummeted by 36.91% to -$516.8 million in 2021, then fell by 10.90% to -$573.2 million in 2022, then climbed by 14.49% to -$490.1 million in 2023, then soared by 38.44% to -$301.7 million in 2024.